The metabolic syndrome consists of a constellation of factors that increase the risk of cardiovascular disease and type 2 diabetes. Recent estimates indicate that the metabolic syndrome is highly prevalent in the United States, with an estimated 24% of the adult population affected.
1 Its clinical identification is based on measures of abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, and glucose intolerance.
2 The etiology of this syndrome is largely unknown but presumably represents a complex interaction between genetic, metabolic, and environmental factors including diet.
3,4 Several recent studies also suggest that a proinflammatory state is one component of the metabolic syndrome.
5-8 Moreover, evidence has accumulated indicating that low-grade inflammation is associated with endothelial dysfunction.
9,10